IBM® SPSS® Amos is a powerful structural equation modeling (SEM) software helping support your research and theories by extending standard multivariate analysis methods, including regression, factor analysis, correlation and analysis of variance. Build attitudinal and behavioral models reflecting complex relationships more accurately than with standard multivariate statistics techniques using either an intuitive graphical or programmatic user interface. 
AMOS is an additional package that works alongside SPSS, but is a separate product. For regular IBM SPSS installations, please see this article

Quick Information

LICENSE TYPE: Concurrent User
REQUIRES VPN: Yes, if off site
PLATFORM: Windows only

Who is licensed to use IBM SPSS AMOS?

All Faculty, Staff and Students are licensed to use IBM SPSS AMOS on MSU Denver owned computers.

How do I request access to IBM SPSS AMOS?

IBM SPSS AMOS is available to all users on their MSU Denver issued PC laptops through Software Center. It is not available for Mac computers, per the vendor. If you require IBM SPSS AMOS to be installed in a department lab, please submit a Software Request for University Devices so that we can schedule that deployment.

How do I access IBM SPSS AMOS?

You will need the GlobalProtect client to be installed and access granted to run IBM SPSS AMOS outside of the university network. For more information or to request access please view What is GlobalProtect? knowledge base article. Once you have enabled GlobaProtect and installed IBM SPSS AMOS from one of the methods above, you can launch the application from your Start menu, the application will connect to your license server and you will be able to use it.

If you require assistance using the application, please contact your instructor, department tutor, or supervisor for help.

If you experience trouble installing the application, you receive license errors, or you feel it is not running correctly, please submit a Software Issues & Errors request.

Print Article


Article ID: 142798
Wed 4/20/22 10:07 AM
Mon 4/3/23 11:54 AM